Regulations, Legislation & Enforcement

Cara Welch named permanent director of ODSP at FDA

Cara Welch named permanent director of ODSP at FDA

By Stephen Daniells

The US Food and Drug Administration has announced that Dr Cara Welch will be the new permanent director of its Office of Dietary Supplement Programs. The announcement was welcomed by industry trade groups.

Factoring CBD into the athletic equation

Factoring CBD into the athletic equation

By Danielle Masterson

This year’s Sports & Active Nutrition Summit event launched with a focus on CBD in sports nutrition. While CBD/hemp products are still in a federal regulatory gray area, that hasn’t stopped product developers from flooding the market with new offerings....

Fmali v Heckler: The landmark herb case that changed the industry

In memory of Ben Zaricor, 1947-2022

Fmali v Heckler: The landmark herb case that changed the industry

By Stephen Daniells

It started with ten-speed bicycles and ended with an Appeals Court decision in 1983 that changed the herb industry and knocked FDA down a peg. Four decades later, it’s time to shine the spotlight on this game-changing court case.

Getty Images / MysteryShot

CBD price per mg trending down, report finds

By Danielle Masterson

Despite a whopping 3,561% gap between the most expensive and least expensive products across the CBD industry, the overall category is getting cheaper for consumers.

Key takeaways from Sports & Active Nutrition Summit

Key takeaways from Sports & Active Nutrition Summit

By Hank Schultz

The Sports & Active Nutrition Summit returned as an in person event in San Diego earlier this month, breaking attendance and engagement records along the way. Here are some of the key takeaways from the NutraIngredients-USA staff.

Getty Images / altmodern

Navigating the legal landscape of weight loss supplements

By Danielle Masterson

Over 42% of adults in the US are considered obese—giving weight loss brands easy marketing fodder amid the obesity epidemic. Unfortunately, this category of supplements has a checkered history, and has become labeled as one of FDA's problem children.

©Getty Images - Ildo Frazao

Bar association panel takes FDA to task over NDI enforcement

By Hank Schultz

A perplexing attitude towards enforcement on the part of federal regulators leaves the dietary supplement industry with little incentive to file New Dietary Ingredient Notifications, participants in a legal panel asserted recently.

Photo courtesy of the Consumer Healthcare Products Association

CHPA debuts consumer resource for understanding supplement labels

By Hank Schultz

The Consumer Healthcare Products Association has made available an online informational tool for consumers that will help them decipher the Supplement Facts panels on product labels. It’s part of CHPA’s move to raise its profile in the dietary supplements...

Getty images /  skynesher

Leafreport finds over half CBD products mislabeled

By Danielle Masterson

The CBD watchdog released a market analysis, revealing that of the 221 products tested, only 40% matched the labeled CBD strength and many contained the wrong type of CBD.

©Getty Images - Eugenio Marongiu

Guest article

AHPA celebrates regulatory victories during year that tested industry's resilience

By By Michael McGuffin, President, American Herbal Products Association (AHPA)

As the 24th month of 2020 (or so it feels) comes to a close – the herbal and natural products industry continues to adapt to challenges brought on by the global pandemic and move our industry forward. From regulatory progress made virtually to creative...

©Getty Images - Klaus Vedfelt

Guest article

Industry needs consensus in 2022, CRN says

By Steve Mister, President and CEO, Council for Responsible Nutrition

As the dietary supplement industry turns the corner to 2022, a range of challenges confronts us— supply chain disruptions, staffing shortages, and inflationary pressures, to name a few. Some difficulties must be addressed individually, but I suggest the...

©Getty Images - serggn

Another phenibut product shows up in warning letter

By Hank Schultz

An FDA warning letter to the marketer of a product containing phenibut took the company to task over noncompliant disease claims but made no mention of the legal status of the ingredient itself.

©Getty Images - Nastco

USP commentary sounds safety, quality alarm on delta-8 THC

By Hank Schultz

The United States Pharmacopeia (USP) has published a commentary raising potential safety and quality control concerns about the delta-8 THC products flooding the market. The document also raised issues with other cannabinoids that are being isolated...

Follow us

Products

View more

Webinars